GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
21.39
-0.82 (-3.69%)
At close: May 15, 2026, 4:00 PM EDT
22.95
+1.56 (7.29%)
Pre-market: May 18, 2026, 5:29 AM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $1.47 billion as of May 18, 2026. Its market cap has increased by 119.68% in one year.
Market Cap
1.47B
Enterprise Value
1.20B
1-Year Change
119.68%
Ranking
Category
Stock Price
$21.39
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.47B, an increase of 81.55%. That is a compound annual growth rate of 12.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.47B | 86.29% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 1.40B |
| Bicara Therapeutics | 1.33B |
| Biohaven | 1.32B |
| SELLAS Life Sciences Group | 1.32B |
| Wave Life Sciences | 1.30B |
| MapLight Therapeutics | 1.30B |
| ArriVent BioPharma | 1.30B |
| Fortrea Holdings | 1.29B |